Altera Digital Health brings ambient AI scribe natively into Sunrise EHR with Brooklyn pilot
Altera Digital Health made Sunrise Thread AI generally available in November 2025 and by September 2026 had announced a pilot at University Hospital at Downstate in Brooklyn, embedding ambient clinical documentation directly inside its Sunrise EHR platform.

The native EHR integration model eliminates the context-switching burden of third-party ambient scribe add-ons, making the architectural approach a meaningful differentiator for health systems already running Sunrise.
Altera Digital Health made Sunrise Thread AI generally available on 18 November 2025, positioning the tool as a native ambient scribe and documentation assistant built directly into its Sunrise electronic health record platform. Less than a year later, on 22 September 2026, the company announced that University Hospital at Downstate — an academic medical centre in Brooklyn — had begun piloting the technology, according to a press release issued via Business Wire.
What the Tool Does
Sunrise Thread AI is designed to capture patient-provider conversations in real time and convert them into structured visit summaries within the Sunrise EHR. Clinicians can access the tool from either desktop or mobile devices, meaning it can travel with a provider across care settings without requiring a dedicated workstation.
The core proposition is straightforward: by automating the conversion of spoken clinical encounters into structured documentation, the tool aims to reduce the time clinicians spend on administrative tasks after — or during — patient visits. How significant that burden is in practice remains a matter of active debate across the healthcare sector; the package does not include a verified study quantifying the ratio, so no specific figure is cited here.
Altera's approach embeds the ambient scribe natively inside the EHR rather than layering it on top as a third-party add-on — a design choice the company says simplifies deployment and preserves existing clinical workflows.
The Brooklyn Pilot
University Hospital at Downstate, described in the 22 September 2026 Business Wire release as an academic medical centre in Brooklyn, is the named pilot site. The announcement does not include specific metrics on physician numbers, encounter volumes or outcomes at this stage; such figures, where circulated, originate from vendor communications and have not been independently verified by this publication.
The hospital's patient population and institutional affiliations — including any relationship to a broader university health sciences system — are noted in secondary coverage but are not independently confirmed against institutional primary sources within this research package, and are therefore not reported here.
Market Context
Ambient clinical documentation is an active and competitive segment of healthcare AI. Several vendors are developing or have commercially launched tools in this category. This publication has not independently verified the ownership structures, funding status or market positioning of named competitors against primary sources included in this package, and so no competitive comparison is drawn here.
What the verified record does show is a clear sequence: Altera moved Sunrise Thread AI from announcement to general availability in November 2025, then secured a named academic medical centre pilot announcement by September 2026 — a roughly ten-month commercialisation timeline from launch to a publicly disclosed hospital deployment.
Why It Matters
For health systems already running Sunrise EHR, the native integration is analytically significant. Adding an ambient scribe as a bolt-on requires clinicians to context-switch between systems; building it into the EHR eliminates that friction. Whether that architectural advantage translates into measurable adoption gains over standalone ambient AI tools remains to be seen, and Altera has not published outcome data from the Downstate pilot in the materials reviewed for this article.
From a product-strategy perspective, the pairing of a general availability announcement with a named academic medical centre pilot — rather than a community hospital — also carries signalling value. Academic centres typically operate under more demanding documentation requirements and train future clinicians, meaning a successful deployment at such an institution can carry disproportionate reputational weight in vendor evaluations at other health systems.
What Is Not Yet Confirmed
In the interest of transparency, this article omits several claims that appear in secondary coverage but could not be verified against primary sources in the research package:
- The precise institutional relationship between University Hospital at Downstate and any affiliated university health sciences entity
- Any quantified measure of documentation burden reduction from the pilot
- Specific competitor funding rounds or partnership announcements
- Demographic or payer-mix characterisations of the hospital's patient population
Readers seeking those details should consult Altera's official newsroom and the hospital's own published materials directly.
The Fin Desk Newsroom publishes verified reporting on the developments shaping fintech, payments and modern financial infrastructure.
Related Stories

Huntington National Bank launches Kyriba-powered Intelligent Treasury platform for corporates
Huntington National Bank has launched 'Intelligent Treasury,' a corporate treasury platform built with liquidity-performance fintech Kyriba, aimed at consolidating operations spread across multiple banks, ERP systems and fintech providers. The announcement follows a related Treasury Management Connectivity Ecosystem initiative the bank disclosed in October 2025.

FIS and Toast CFOs Exit in Quick Succession as Shares Slide on Leadership Uncertainty
FIS has named Alexandra Brooks interim CFO after James Kehoe's departure, coinciding with a cut to its FY26 guidance that sent shares down roughly 15%. At Toast, Elena Gomez is stepping down despite a quarter that beat analyst estimates, with Michael Senno named as successor.

Revolut hits $115bn valuation in secondary share sale, up 53% from November 2025
Revolut has confirmed a $115 billion valuation following a secondary share sale priced at $2,017 per share, up 53% from the $75 billion level established in a prior secondary transaction in November 2025. The deal provided liquidity for existing shareholders and employees but did not add primary capital to the company.

Bilt Agrees $300M Deal to Acquire Sports Loyalty Platform LAVA
Bilt Rewards has announced a $300 million agreement to acquire LAVA, a loyalty technology platform serving 56 professional sports franchises across the NFL, NBA, MLB, NHL and MLS. The deal, announced 2 November 2026, remains pending with no closing date or regulatory clearance confirmed.
The essential developments in modern finance
The essential developments across fintech, payments and modern finance — delivered to your inbox.
Free. No spam. Unsubscribe anytime.